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Background: Evidence-based clinical practice guidelines may improve treatment quality, but the uptake of
guideline recommendations is often incomplete and slow. Recently new low back pain guidelines are being
launched in Denmark. The guidelines are considered to reduce personal and public costs. The aim of this study is
to evaluate whether a complex, multifaceted implementation strategy of the low back pain guidelines will reduce
secondary care referral and improve patient outcomes compared to the usual simple implementation strategy.
Methods/design: In a two-armed cluster randomised trial, 100 general practices (clusters) and 2,700 patients aged
18 to 65 years from the North Denmark region will be included. Practices are randomly allocated 1:1 to a simple or
a complex implementation strategy. Intervention practices will receive a complex implementation strategy,
including guideline facilitator visits, stratification tools, and quality reports on low back pain treatment. Primary
outcome is referral to secondary care. Secondary outcomes are pain, physical function, health-related quality of life,
patient satisfaction with care and treatment outcome, employment status, and sick leave. Primary and secondary
outcomes pertain to the patient level. Assessments of outcomes are blinded and follow the intention-to-treat
principle. Additionally, a process assessment will evaluate the degree to which the intervention elements will be
delivered as planned, as well as measure changes in beliefs and behaviours among general practitioners and
patients.
Discussion: This study provides knowledge concerning the process and effect of an intervention to implement low
back pain guidelines in general practice, and will provide insight on essential elements to include in future
implementation strategies in general practice.
Trial registration: Registered as NCT01699256 on ClinicalTrials.gov.
Keywords: General practice, Intervention studies, Guideline, Health plan implementation, Low back pain, Referral,
ConsultationBackground
The prevalence of low back pain (LBP) in any form is be-
tween 25% and 30%. Among LBP patients, about 50% have
consulted their general practitioner (GP) for LBP during
the last year [1]. LBP generates personal, social, and public
costs, and in 2005, Danish costs for treatment, sick leaves,* Correspondence: a.riis@rn.dk
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reproduction in any medium, provided the orand incapacity benefits were estimated at 16.8 billion DKK
(~ 2.3 billion €) [2]. Recently, new clinical practice guide-
lines were introduced in Denmark, which include advice
for primary care on assessment and treatment of LBP
patients [3].
The new guidelines are expected to improve overall
treatment and they describe the roles of different health-
care providers and define when a GP should refer a patient
to a secondary care spine centre. Primary care treatment
is considered sufficient for most LBP patients, and second-
ary referral is usually only recommended if the patient. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ment. The guidelines include recommendations to the
GPs on advising the patients to stay as physically active as
possible and to evaluate the need for analgesics and sup-
plementary treatment (e.g., manual therapy or exercises)
[3]. More patients are expected to improve by following
the guidelines, and referral to secondary care can thus be
reduced.
New guidelines are a potential vehicle for changing GP
behaviour and securing implementation of evidence-
based knowledge into clinical practice. However, imple-
mentation strategies with simple, passive diffusion of
guidelines, such as simply making newsletters available
and other strategies based on information dissemination,
have shown insufficient results [4-6]. Consensus regard-
ing the optimal content of components in an interven-
tion strategy has not yet been established, but a review
on the effectiveness of clinical guideline implementation
suggests the use of a complex approach with active en-
gagement of GPs throughout the process [7]. Activities
such as the use of computer-based reminder systems,
educational visits, and the use of several activities in
combination have shown positive effects in changing GP
behaviour [8].
Knowledge concerning how to introduce new guide-
lines in general practice, however, is sparse, and further
knowledge is needed in order to support guideline com-
pliance among GPs and to ensure best evidence-based
practice. The aim of this study is to compare a complex
implementation strategy with a simple implementation
strategy during the implementation of the new LBP
guidelines in the North Denmark region. Primary and
secondary outcomes pertain to the patient level. A
process evaluation pertains to both practice and patient
level. A concomitant health economic analysis will be
described in a separate protocol.
Overall theory of changing general practice behaviour
A recently proposed framework for changing clinical
behaviour argues that if behaviour change is to be gener-
ated, addressing the GP’s capability, opportunity, and
motivation is required [9]. The intervention outlined in
this study’s protocol supports the GP’s ability to perform
an appropriate physical examination and thus enhance
GP’s physical capability and thereby support GP’s
provision of guidelines. Pop-ups and discussions with
guideline facilitators aim to improve the GP’s psycho-
logical capability to treat LBP. The practical opportunity
for GPs to follow the guidelines is, in our setting, sup-
ported through a new referral option for patients with
social needs. A social, conducive environment for the
process of change is established by conducting practice
meetings with guideline facilitators and at small group
educational meetings. The GP’s reflective and emotionalmotivation is addressed through reminders, mouse pads,
feedback of monitoring LBP treatment, and discussions
with peers and guideline facilitators about the guidelines
and the GP’s experiences with the implementation of the
guidelines.
Through addressing all of these components, a coordi-
nated set of activities was developed to generate an
intervention profile targeted at changing GP behaviour,
through better guideline compliance, in order to im-
prove LBP treatment. All activities in this project fall




This is a two-armed 1:1 cluster randomised controlled
trial (CRCT) comparing a control and an intervention
group of Danish GP practices. Clusters are defined as
patients originating from the same practice. A cluster
randomisation was chosen for practical reasons and to
prevent possible contamination by asking GPs to treat
patients as two groups. The study will include 2,700 pa-
tients through stepwise inclusion of 100 practices (Figure 1).
In Denmark, almost all secondary-care treatment re-
quires GP referral [10]. All participating GPs receive the
usual implementation strategy and passive supportive
activities, which include the opportunity to refer pa-
tients to an evaluation at the Department of Social
Medicine, as well as activities aimed at the inclusion of
patients. In addition, intervention practices receive a set
of proactive activities including facilitator visits, elec-
tronic stratification tools, quality reports, and feedback
on LBP treatment.
Study preparation has been aimed at investigating how
to change GPs’ behaviours and how to motivate GPs to
participate in the study. Single activities such as new
stratification and screening tools in the electronic med-
ical record system, electronic pop-ups, facilitator visits,
and patient questionnaires have been tested separately
prior to this study. In addition, prior to the study, a full-
package test involving installation of pop-ups, GP ques-
tionnaires, facilitator visit, and facilitator questionnaire
was performed, inspired by the stages in ‘Interventions
to Change the Physician Performance’ [11] (Table 2).
Based on small-scale testing in selected practices, we
subsequently adjusted the intervention.
Eligibility and recruitment
Inclusion and exclusion criteria for general practices
General practices in the North Denmark region are
eligible for inclusion. Excluded are practices without the
electronic data capture program Sentinel, which links
the electronic medical record system to the Danish Gen-
eral Practice Database (DAMD), hosted by the Danish
Table 1 Activities aimed at changing GP behaviour






Usual activities (Control and intervention practices)
Regional information meetings X X
Regional website and written material X X
Small group continuing medical education X X
Passive supportive activities (Control and intervention practices)
Social medicine referral opportunity X
Electronic medical record pop-ups X X
Financial incentives X
Posters reminding of guidelines X
Mouse pads guiding diagnosis coding, medical record procedures, and
reminding of guidelines
X X
Pro-active supportive activities (Intervention practices)
Facilitator visit X X
Feedback/quality assurance X X
Info-folder delivered at facilitator visit X X
STart Back stratification tool* X X
Social medical screening tool* X X
Activities aimed at changing GP behaviour sorted under capability, opportunity, and motivation. *STarT Back Tool and the SOS screening tool are built into the
GPs’ electronic medical record and are filled in at the patient’s first or second consultation regarding LBP.
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were linked to DAMD). Individual GPs will be excluded
if they participated in the pilot testing of the study. By
October 2011, the North Denmark region had 191 gen-
eral practice provider numbers representing 332 GPs.
The total number of patients in the North Denmark
region was 579,829, giving an average of 3,035 listed
patients per practice [12].
Recruitment of general practices
At local meetings for GPs, one of the investigators
(MBJ) informed colleagues about the new guidelines for
treatment of LBP and encouraged participation in the
study. The GPs will be invited to participate in this study
by electronic mail, written letters, and calls from the
Quality Unit for General Practice in the North Denmark
region (Nord-KAP). To support enrolment, GPs are
informed that participation will improve their skills in
managing patients with LBP, will help implement the
new guidelines, and will provide a new opportunity to
refer patients with LBP and concomitant complex social
problems to the Department of Social Medicine. In
addition, GPs in the control group are paid 1,500 DKK
(~200 €) and GPs in the intervention group are paid
2,500 DKK (~333 €) for participation.
Inclusion and exclusion criteria for patients
Included are patients aged 18 to 65 years presenting
with LBP, with and without leg pain, based on ICPC-2diagnosis coding L02, L03, L84, or L86 [13]. Excluded
are patients with red flags (signs of serious pathology),
pregnant women, and patients with insufficient Danish
language skills. Excluded patients are registered in
DAMD and, together with basic data regarding excluded
patients (number, gender, age), will be used to evaluate
the selection of patients.
Recruitment of patients
For recruiting patients, when a patient with LBP consults
a GP, a data-capture program pops up in the electronic
medical record. This pop-up contains a question concern-
ing whether the patient agrees to be contacted regarding
questionnaire reminders. If the patient agrees, the GP
hands out an envelope containing an informational letter
about the study, a questionnaire, and a reply envelope with
prepaid postage. In the informational letter, patients are
encouraged to give informed consent to participate with
questionnaires. The consent is given in the first of four
questionnaires. Filling in the questionnaire can be done
either electronically or by returning the written question-
naire. The general practices will receive posters and mouse
pads with LBP diagnoses and pop-up information to re-
mind the GPs of the study. The DAMD database [14] will
supply weekly lists of included patients. Reminders will be
sent to patients who have agreed to be contacted but who
have not filled out a questionnaire. The progress of re-
cruitment will be evaluated every fortnight, and if inclu-
sion is less than one patient per fortnight per participating
Figure 1 Chart of expected flow of clusters and patients throughout the trial. Actual numbers of clusters, average cluster size, and variance
of cluster sizes, number of patients contributing data for the primary outcome, as well as number of patients participating with questionnaires
will be concluded in reporting of results. *In three practices, single GPs are excluded from participation without excluding the total practice.
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inclusion.
Implementation activities offered to all participating
practices
All practices receive usual guideline implementation, which
includes small group continuing medical education
meetings, electronic newsletters describing the guide-
lines [15], and an invitation to participate in regional
information meetings. All participating practices are
also offered passive supportive activities including re-
structuring of the electronic medical record, activities
reminding of patient inclusion, and the opportunity to
refer patients to the Regional Department of Social
Medicine for evaluation.
Implementation activities offered to intervention practices
In addition to the supportive activities, the intervention
practices will receive three additional active supportive
activities: guideline for facilitator visit; two patient risk-
stratifying tools (Start Back Tool and SOcial risk Screening(SOS) questions; and data feedback on LBP treatment.
The following details each of these items:
1. Five primary care physiotherapists are guidelines
facilitators. They all have a special certification in
LBP assessment and have participated in a ten-hour
training course covering the new LBP guidelines in
connection with this study. To unify and optimise
facilitator visits, the course included lectures and
supervised role-playing on how to introduce change
in clinical behaviour. The facilitator will visit the
practice at inclusion and inform about treatment of
LBP according to the new guidelines. Prior to
patient inclusion each practice will be offered a one
to two hour facilitator visit. After four weeks of
patient inclusion, a half-hour follow-up visit or
contact by phone or mail will be offered.
2. Two stratifying tools are made available to identify
patients at risk of persistent symptoms:
a. The STarT Back Tool divides patients into low,
medium, or high risk of prolonged symptoms and




To develop an intervention model based on
theoretical understanding and empirical
research
In the North Denmark region general practice, a complex strategy for new
low back pain guideline implementation will be tested to study behaviour
change (professional practice) and clinical results (patient outcomes).
Stage I: testing and
remodelling
Experiments with activities of the intervention in
artificial settings
Testing and remodelling structural medical record changes including GP
testing of STarT and SOS with patients. Testing and remodelling different
questionnaires on volunteers without LBP, GPs, researchers, and patients.
Testing and remodelling LBP patient completed questionnaires.
Developing electronic generated feedback quality reports for GPs. Testing




Full package intervention in selected units of
the target group with close monitoring
Full package delivery of facilitator visit at a general practice, use of
stratifying tools and changes in the medical record. Inviting patients to
electronic or paper version questionnaire. Monitor whether data imputed
in medical records and patient questionnaires will be stored at DAK-E,
delivered to external database provider, and available for data retrieval.
Stage III: efficacy
studies
Cluster RCT with ideal intervention, delivery,
randomisation, control group and close
monitoring
Randomised controlled trial. Inclusion of provider numbers and patients.
Use of guideline facilitator visits. Use of stratifying tools. Use of supervising
facilitator contacts and feedback quality reports. Monitoring intervention
delivery. Monitoring guideline compliance. Monitoring treatment courses.





Routine intervention delivery and ad hoc or
routine monitoring
Cost-effectiveness analysis and other health economic analyses are planned
and will be described in a separate protocol.
Stages in study development and for intervention performance.
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a requirement that those delivering the treatment
for high-risk patients to have specialised training in
targeting psychological aspects.
b. The SOS questions (Additional file 1) inquires
whether the LBP raises concern about work
ability, whether the patient plans to have, or
already has, compensation claims or seeks
pension, or whether there are any other
important issues that could be barriers for
recovery. The GPs may use the two risk-
stratifying tools at either the initial or the second
consultation for LBP. The tools may be viewed in
the context of the theory of coloured flags [18]
and incorporate biological, psychological, and
social aspects. Patients with red flags (serious
pathology) are excluded. Yellow flags (beliefs,
emotional responses, and pain behaviour) are
addressed in the STarT Back Tool. Blue flags
(perceptions about the relationship between work
and health), black flags (system or contextual
obstacles such as legislation, injury claim
conflicts, etc.), and orange flags (psychiatric
factors) are encompassed in the SOS questions.
3. Feedback on assessment, treatment, and referral of
LBP patients during the project: The GPs have
access to their own statistics regarding guideline
compliance from the DAMD database and may
choose to discuss the statistics with their guideline
facilitator.Data collection
Collected data for this project will be kept and merged
by an external provider using the unique personal identi-
fication number (CPR number) that is assigned to all
Danish citizens. Data are collected from the guideline
facilitators, pop-ups in the GPs electronic medical rec-
ord (DAMD database), GP questionnaires, patient ques-
tionnaires, and regional registries (Figure 2).
Data capture from the medical record pop-ups
The pop-ups for this project are built into the medical
record systems and are activated when the GP enters an
ICPC-2 code for LBP [14]. The pop-up at the initial con-
sultation includes questions concerning duration of pain,
previous LBP episodes, triage (unspecific LBP, nerve root
pain, and red flags/serious pathology), and new appoint-
ments. At succeeding consultations, the pop-ups contain
questions on symptoms, recommended and applied sup-
plementary treatment, and future planned GP visits. The
SOS questions and the STarT Back Tool only appear for
the intervention practices and can be filled in either at
first or second consultation. Every consultation contains
a pop-up question on whether the patient has been re-
ferred to secondary care treatment (primary outcome).
Pop-ups will cease to appear 12 weeks after the first
consultation.
Patient questionnaires
Patients who wish to participate with questionnaires are
requested to fill in a questionnaire immediately after the
Figure 2 Illustration of the monitoring procedure. The first column depicts purpose of measuring; the second column classifies type of
measurement; the third column describes type of actions included for measuring; and the fourth column depicts original data storage. All data
are merged to the study database.
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In case the patient does not respond to a questionnaire,
reminders are sent following one- and two-week delays. In
the first questionnaire, patients are asked for baseline
characteristics on educational level, co-morbidity, as well
as the STarT Back Tool questions. Included in the first
questionnaire and repeated in the next three question-
naires are questions on the secondary outcomes and about
advice received and advice followed.
Regional registries, facilitators, and GPs
Data regarding provider numbers and associated GPs
will be delivered by the Primary Care Unit in the North
Denmark region. The regional Department of Health
Planning and Quality provide data on primary care
reimbursements (i.e., visits to GPs, physiotherapists,
and chiropractors).
Following the initial visit and at later contacts with the
intervention clinics, the guideline facilitator will log on
to the project database and fill out a questionnaire torecord which components of the intervention were
delivered (Table 3).
At inclusion and after six months, GPs are asked to fill
out a questionnaire. They are asked about their capability,
opportunity, and motivation for LBP treatment and their
views on implementation strategies.
Data completeness, quality, and security
Every fortnight, the study group will perform evalua-
tions of the number of included patients, as well as
completion and accuracy of data forms, and act on any
problems (missing data, slow inclusion, etc.). Data com-
pleteness regarding referral to secondary care treatment
(primary outcome) is expected to be between 98 and
100%. Data completeness from patient questionnaires
(secondary outcomes) is expected to be about 80%.
Paper-version questionnaires will be double keyed into
the database. Pop-up data are sent daily to the DAMD
database, and from the DAMD to the project database
on a weekly basis. The project database is provided with
Table 3 Registrations from facilitators
Topics at the initial guideline
facilitator visit
Only intervention group practices
Answer Appearance of textbox
when answering no.
Medical history Yes/No √
Clinical examination Yes/No √
Triage Yes/No √
ICPC-coding Yes/No √
Patient general advices Yes/No √
Re-evaluation Yes/No √
STarT Back Tool Yes/No √
SOcial Screening questions Yes/No √
Supplementary treatment Yes/No √
Referral to secondary care Yes/No √
Guideline hand-outs Yes/No √
Pop-up instructions Yes/No −
(If yes) – at the computer screen Yes/No −
Duration of visit Minutes −
Participants Numbers −
Follow-up appointment made Yes/No √
Overview of data collection from facilitator visits. The questions are entered
into the database by the facilitator after the initial visit. Data concerning dates
and topics in following contacts between facilitators and practices will be
entered as well.
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be performed daily.
Primary outcome
The primary outcome measure is GP referral to secondary
care within 12 weeks after initial GP appointment. A 5%
lower referral rate is considered clinically relevant and
is expected in the intervention group compared to the
control group. To validate if GPs secondary-care refer-
ral results in actual secondary care treatment, data is
collected from the North Denmark region administra-
tion on diagnoses.
Secondary outcomes
Changes from baseline to four, eight, and 52 weeks are
evaluated for the following secondary outcomes: phys-
ical function, evaluated by the 23-questionnaire Roland
Morris Patrick (for the individual patient, a three-point
improvement is considered clinically relevant); pain
score, evaluated by a numerical rating scale from ‘no
pain’ to ‘maximal pain’ (score 0 to 10; a 30% change is
considered clinically relevant for an individual patient);
health-related quality of life, evaluated by EQ-5D score;
patient satisfaction (treatment; a 30% change is consid-
ered clinically relevant for an individual patient); patient
satisfaction (outcome; a 30% change is considered clin-
ically relevant for an individual patient); employmentstatus (have work, yes/no); and sick leave (number of
days).
Tertiary process outcomes
The following three areas will be described in relation to
process evaluation: Did general practice receive the
intended implementation activities? Did the intervention
change the skills, beliefs, and behaviour of the GPs? Did
the intervention change the beliefs and behaviour of the
patient? The three areas are elaborated below.
Evaluating the delivery of the implementation
Actual implementation delivered to interventions prac-
tices is monitored by the following items:
1. Delivered intervention at the initial guideline
facilitator visit.
2. Use of STarT Back Tool and SOS questions.
3. Follow-up contacts with facilitators.
4. Use of data feedback by the GPs.
Evaluating skills, beliefs and fidelity of the GP and
guideline compliance
1. Skills are evaluated by asking about the GP’s
satisfaction with own ability to handle LBP patients
and if there are aspects that the GP wants to
improve.
2. Beliefs of the GPs are evaluated by six questions on
GP agreement with guideline recommendations. GPs
are asked questions regarding patient history, patient
examination, patient information, advice to stay
active, and regarding referral to supplementary
treatment in case the patient does not improve.
3. Behaviour of the GPs are evaluated by the referral
rate in relation to the risk stratification (STarT Back
Tool) and SOS questions, and the proportion of
patients who have not improved by four weeks who
have been advised to receive supplementary primary
care treatment.
Evaluating the beliefs and behaviour of the patient
Use of supplementary treatment, use of analgesics, and
changes in Roland Morris Questions 9 and 23 in patient
questionnaires will be used to evaluate changes in pa-
tient beliefs and behaviours. Changes will be measured
eight weeks after the patient’s initial GP appointment.
Study preparation
Prior to the study, the complex implementation strategy
was developed, tested, remodelled, and retested in order
to achieve maximum effect and evaluate the logistical
aspects of the study [11].
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sample of 624 practices using diagnosis from the past
12 months, including data from the GPs coding >70%
of their contacts, was evaluated. The data included
2,000,612 patients and showed the following prevalence
of diagnoses: L02, 2.73%; L03, 1.57%; L84, 0.92%; and L86,
0.84% [H. Schroll: Danish Quality Unit for General
Practice. December 2012]. With stepwise inclusion of
practices, a conservative estimate of duration of patient
inclusion over twelve months was made.
To assess additional explanatory variables other than
the intervention itself, analyses were performed on other
variables. Registry data were obtained on all GPs in the
North Denmark region regarding referrals to regional
hospitals in 2011. LBP diagnoses (ICD10 diagnoses
DM47, DM48, DM51, DM53, and DM54) were included.
Analyses of these data showed differences in referral rates
for practice size (t test of small vs. large practice, p = 0.11,
Sd test, p = 0.023), urbanisation (t test of rural vs. mixed,
p = 0.01), and educational level (Sd test of low vs. high,
p = 0.02). It was decided to both stratify and adjust for
practice size and possibly adjust for level of urbanisation
and level of education.
The intervention strategy was developed by the re-
search group based on the COM model [9]. Potential
barriers to implementation and possible components
that could address these barriers were evaluated in rela-
tion to feasibility and cost. The subsequent intervention
components were tested in three practices and either
rejected or adjusted.
Pop-ups with the STarT Back Tool and the SOS ques-
tions were tested in three general practices using different
medical record systems. Adjustments were made to ease
use and to support GP guideline compliance through the
structure of the pop-ups. Mouse pads (A4-format) and
posters (A3-format) were tested and produced with help
from two GPs at the Quality Unit for General Practice in
the North Denmark region (NordKAP). Patient question-
naires were tested both as paper questionnaires and in the
electronic form to evaluate different aspects (readability,
time use, etc.). In all, 40 patients answered paper question-
naires in different variations. GP questionnaires were
tested on three GPs and facilitator registrations were
tested after a full-scale facilitator visit test.
Prior to initiating the study, a full-scale evaluation of a
facilitator visit was conducted. A practice was repre-
sented by four GPs and two nurses. One of the GPs had
himself worked as a facilitator in general practice and
gave feedback after the test. The two authors AR and
MBJ participated in order to make final adjustments for
the planned facilitator visits.
The ongoing inclusion of practices over several months
was utilised for small adjustments in order to address bar-
riers for patient inclusion and the use of this project’sintervention elements. Inclusion started with four small
practices. These practices were followed closely and
possible problems were corrected before the inclusion
of additional practices.
Statistics
Analyses will be performed according to the CONSORT
guidelines [19]. Data will be analysed according to the
intention-to-treat principle. We will obtain descriptive
statistics for process measures; baseline characteristics
and outcome measures will be presented as mean (SD)
or numbers (%) with 95% confidence intervals, if normally
distributed, or otherwise as medians (quartiles). A Gener-
alised Estimating Equation model with logit link and
exchangeable correlation will be carried out. Primary
outcome (12-week referral rates) will be analysed in
logistic regression models and with respect to provider
number cluster effects. Employment status will be ana-
lysed by logistic regression models. The other secondary
outcomes (Roland Morris Questionnaire, numerical
pain rating, EQ-5D, patient satisfaction, and sick leave)
will be analysed with practice number as a random
effect in a linear mixed effects model with provider
number as the intercept in profile analyses.
Primary exposure is allocation group (intervention or
control group) stratified by the size of the practices. Fol-
lowing practice number, related baseline variables will be
analysed and possibly adjusted for size of practice
(≤2,000, 2,001 to 5,000, >5,000 listed patients), urbanity,
and degree of received components at baseline (partici-
pation in regional information meeting [y/n] and read
newsletter [y/n]). The following patient-level-related
baseline variables will be analysed and possibly adjusted
for educational level, age, gender, co-morbidity, duration
of pain, and earlier episodes of LBP.
Sample size
The control groups’ referral rate to secondary care is
expected to be 18%. The intervention groups’ referral
rate is expected to be reduced to 13%. Hence, this study
is powered to detect a 5% point between groups differ-
ence in secondary care referral rates. Considerations of
possible cluster effects led us to analyse possible inter-
correlations. We analysed whether referral rates were the
same between provider numbers in the North Denmark
region in 2011. The data did not support any differences
in referral rates between provider numbers. Assuming no
cluster effect seemed unrealistic, and for that reason, a
conservative estimate of a 16% cluster effect was used
based on earlier studies on cluster effects in primary care
[20]. Study size was estimated on an assumption of 90%
power, a 5% level of significance, and a cluster effect of
16%. These assumptions lead to a requirement of 1,321
patients in each group. To allow for size difference
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was raised to 2,700 patients from 100 practices (Figure 1).
Randomisation and blinding
Practices are randomised 1:1 to control or intervention
group and stratified by list size (≤2,000 patients, 2,001 to
5,000 patients, >5,000 patients) in random permuted
blocks of two, four, and six. Randomisation was completed
using the Stata program RALLOC. When a general prac-
tice signs up for participation, and after giving informed
consent, the coordinating secretary assigns a participation
number and opens the corresponding sealed envelope
with allocation information.
Allocation is not blinded for the GPs, guideline facili-
tators, or the researchers guiding the facilitators and
intervention practices (Research assistant Pia Christine
Malmstrøm and MBJ). The researchers collecting and
analysing the data (AR and CEJ) are blinded to the ran-
domisation status of the general practice until the statis-
tical analysis has been completed. Patients are told that
the general practice is participating in a research project
and are invited to participate by filling out patient ques-
tionnaires. The patients are told they are participating in
a trial. Most patients will not be aware that it is a rando-
mised trial and they will only know of their allocation if
the GPs choose to inform them.
Ethics
The Regional Scientific Ethics Committee and the Danish
Health and Medicines Authority did not find that any
approval was necessary. The study was registered with the
Danish Data Protection Agency, The Danish College of
General Practitioners, and at ClinicalTrial.gov (registration
number NCT01699256). Patients listed at the included
practices are included without patient consent. Written in-
formed consent from the patients for participating with
questionnaires will be included in the first questionnaire.
Patients may, at any time and without any consequence
for their treatment, discontinue participation in the ques-
tionnaires. Other than filling out and leaving question-
naires, patients will not suffer any harm or inconvenience.
Consent is sought from the participating GPs before the
randomisation.
Trial status
Inclusion of practices started 14 January 2013 and by 2
July 2013; 35 practices and 300 patients are included.
Data collection is continuing and is expected to last until
the end of Year 2013.
Discussion
This study will compare two guideline implementation
strategies to improve LBP treatment and to increase
knowledge about how to implement guidelines in generalpractice. The study is established in cooperation between
the regional bodies involved in planning and implement-
ing the new LBP guidelines and the regional research unit
for general practice.
The study is a large cluster randomised controlled trial
with expected follow-up regarding the main research
question for almost all LBP patients included (referral to
secondary care). Patient-related outcome domains are
covered in full and extend as recommended in the litera-
ture [21]. Development and testing of the intervention
was carried out in 2011 and 2012, and a large-scale
monitoring process has been developed to optimise out-
come measures and also to provide information about the
processes between intervention and outcome measuring.
The success of the guideline facilitators in changing GP
behaviour in LBP management is uncertain. Physiothera-
pists have not previously been used as general practice
guideline facilitators in the North Denmark region, and
how well they will be received is not known. Including
GPs and patients in general practice can be a challenging
task. The IMPLEMENT study planned to include 92
practices and a total of 2,300 patients. After nine
months, however, all 92 practices (112 GPs) but only 29
patients were included, and further recruitment was
abandoned [22]. In this study, several actions have been
taken to support GP inclusion (financial compensation,
information through regional meetings for GPs, letters,
and personal contacts) and patient inclusion (posters at
GPs, mouse pads for GPs, and automatic diagnosis
prompted reminders). Two researchers who are not
blinded for randomisation (MBJ and PCM) will be
proactive in including more practices and encouraging
GPs to hand out envelopes to LBP patients.
This project will study whether the planned interven-
tion is associated with better treatment for LBP patients.
The project will also describe which activities should be
included in future implementation strategies in primary
care for LBP, as well as for other primary care patient
groups for whom new guidelines are planned in the near
future [15].
Additional file
Additional file 1: English translation of the Social medicine
screening question.
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